Filing Flows › Stryker (SYK) › R&D spending
Stryker (SYK) R&D spending by quarter
Stryker's R&D spending was $433M in Q3 2026 (third quarter 2026), -0.2% from Q2 2026. Over the last 7 quarters it ranged from $401M (Q4 2025) to $434M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $433M | -0.2% | +6% |
| Q2 2026 | $434M | +5% | +7% |
| Q1 2026 | $413M | +3% | +2% |
| Q4 2025 | $401M | -2% | — |
| Q3 2025 | $410M | +0.7% | — |
| Q2 2025 | $407M | +0.5% | — |
| Q1 2025 | $405M | — | — |
Q3 2026 at a glance
Stryker, Q3 2026: revenue $6.5B (+8% year over year), operating margin 15.9%, net earnings $753M, operating cash flow $1.5B. The chart follows the revenue to costs, profit and cash.
Questions
What is Stryker's R&D spending?
Stryker's R&D spending was $433M in Q3 2026 (third quarter 2026), -0.2% from Q2 2026.
How has Stryker's R&D spending changed?
Over the last 7 quarters it ranged from $401M (Q4 2025) to $434M (Q2 2026).